Product Information
KETOROLAC 0.4% OPHTH SOLUTION is a generic product labeled by Pacific Pharma, Inc., priced at $12.6737 per ML under NDC 60758077305. Its NADAC has been published 656 times since Mar 12, 2014.
FDA first approved this application on May 30, 2003.
The High Outlier badge above means this manufacturer's average price in the Ketorolac Tromethamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
60758077305
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021528FDA Approved
5/30/2003
On Market Since
11/21/2013
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 0.4% OPHTH SOLUTION has been published 656 times since Mar 12, 2014, and over the history we have for it it has risen 298.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.6737 per ML |
|---|---|
| All-time high | $12.8326 (Feb 11, 2026) |
| All-time low | $3.1773 (Mar 12, 2014) |
| 52-week high | $12.8326 |
| 52-week low | $11.9486 |
| Median price | $9.6786 |
| Average price | $9.7403 |
| Largest weekly change | +89.8% (Apr 23, 2014) |
| Weeks tracked | 656 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ketorolac Tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 0.4% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 0.4% OPHTH SOLUTION, manufactured by Pacific Pharma, Inc., is $12.6737 per ML (NDC 60758077305), effective Sep 30, 2026.
How has the price of KETOROLAC 0.4% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for KETOROLAC 0.4% OPHTH SOLUTION has risen 298.9%. It has been tracked across 656 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for KETOROLAC 0.4% OPHTH SOLUTION?
Since Mar 12, 2014, the NADAC for KETOROLAC 0.4% OPHTH SOLUTION has ranged from a low of $3.1773 (Mar 12, 2014) to a high of $12.8326 (Feb 11, 2026), with a median of $9.6786 per ML.
Are there cheaper alternatives to KETOROLAC 0.4% OPHTH SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KETOROLAC 0.4% OPHTH SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 0.4% OPHTH SOLUTION?
KETOROLAC 0.4% OPHTH SOLUTION (NDC 60758077305) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.